The FDA has now approved Addyi for use in women younger than 65 who have gone through menopause and have HSDD , making it the first FDA-approved pharmacologic option for low sexual desire that spans… | Jennifer R. Berman, MD

Kelly Casperson, MD➖Urologist on Instagram: "- BREAKING NEWS - Today the FDA has announced the expanded approval of Addyi (flibanserin), the first and only FDA-approved pill for low sexual desire in women, to include women who have gone through menopause. This decision marks an important milestone in women’s sexual health and closes a gap in care for millions of postmenopausal women experiencing hypoactive sexual desire disorder (HSDD) and marks a historic first of its kind approval for the FDA.